We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
+16.75%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$226M
AUM Growth
+$79.9M
(+55%)
Cap. Flow
+$74.4M
Cap. Flow
% of AUM
32.94%
Top 10 Holdings %
Top 10 Hldgs %
58.47%
Holding
54
New
20
Increased
12
Reduced
7
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
+$22.1M |
| 2 |
MTEM
Molecular Templates, Inc.
MTEM
|
+$12M |
| 3 |
Sanofi
SNY
|
+$10.6M |
| 4 |
McKesson
MCK
|
+$10.6M |
| 5 |
AAAP
Advanced Accelerator Applications S.A.
AAAP
|
+$8.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$7.98M |
| 2 |
Cardinal Health
CAH
|
+$7.29M |
| 3 |
Medtronic
MDT
|
+$5.89M |
| 4 |
Amgen
AMGN
|
+$5.23M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$5.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 81.66% |
| 2 | Miscellaneous | 12.43% |
| 3 | Consumer Discretionary | 3.48% |
| 4 | Financials | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $28.6M | 12.68% |
44,729
+5,218
| +13% | +$2.88M |
|
|
DYAX
2
DELISTED
DYAX CORPORATION
DYAX
| $25.9M | 11.45% |
+687,600
| New | +$22.1M |
|
|
3
Sanofi
SNY
$107B
| $15.4M | 6.84% |
361,962
+230,691
| +176% | +$10.6M |
|
|
NEOS
4
DELISTED
Neos Therapeutics, Inc
NEOS
| $11.2M | 4.96% |
781,514
+114,785
| +17% | +$1.73M |
|
|
5
McKesson
MCK
$104B
| $11M | 4.89% |
+56,000
| New | +$10.6M |
|
|
AAAP
6
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $9.13M | 4.04% |
+291,877
| New | +$8.11M |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $8.64M | 3.82% |
644,617
-37,689
| -6% | -$454K |
|
|
VSI
8
DELISTED
Vitamin Shoppe Inc.
VSI
| $7.85M | 3.48% |
+240,000
| New | +$7.61M |
|
9
Cigna
CI
$73.7B
| $7.15M | 3.17% |
48,855
+3,362
| +7% | +$462K |
|
|
DMK
10
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $7.12M | 3.15% |
18,838
+169
| +0.9% | +$53K |
|
|
CTIC
11
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $6.51M | 2.88% |
+529,226
| New | +$7.07M |
|
|
ANTH
12
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $6.4M | 2.83% |
172,305
+65,296
| +61% | +$2.88M |
|
13
AbbVie
ABBV
$451B
| $6.15M | 2.72% |
103,809
+9,493
| +10% | +$547K |
|
|
STJ
14
DELISTED
St Jude Medical
STJ
| $5.73M | 2.54% |
+92,800
| New | +$5.85M |
|
|
PFNX
15
DELISTED
Pfenex Inc.
PFNX
| $5.54M | 2.45% |
447,262
+191,959
| +75% | +$2.83M |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $5.48M | 2.43% |
+50,700
| New | +$5.48M |
|
17
Zimmer Biomet
ZBH
$19.2B
| $5.43M | 2.4% |
+54,499
| New | +$5.33M |
|
18
Ascendis Pharma A/S
ASND
$16.3B
| $5.22M | 2.31% |
284,785
+15,000
| +6% | +$263K |
|
19
UnitedHealth
UNH
$353B
| $4.18M | 1.85% |
35,500
-20,484
| -37% | -$2.39M |
|
20
Bristol-Myers Squibb
BMY
$136B
| $3.71M | 1.64% |
53,862
-28,872
| -35% | -$1.91M |
|
|
NTUS
21
DELISTED
Natus Medical Inc
NTUS
| $3.39M | 1.5% |
70,500
+20,500
| +41% | +$949K |
|
|
FOMX
22
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.37M | 1.49% |
415,972
+79,686
| +24% | +$596K |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals
ADMS
| $3.32M | 1.47% |
117,257
+15,491
| +15% | +$261K |
|
24
Addus HomeCare
ADUS
$2.16B
| $2.92M | 1.29% |
+125,526
| New | +$3.16M |
|
25
Merck
MRK
$366B
| $2.87M | 1.27% |
+56,985
| New | +$2.87M |
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Sio Capital Management held 54 positions worth $226M, up 55% from $146M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Sio Capital Management deployed $74.4M of net new capital in Q4 2015, opening 20 new positions and adding to 12 existing holdings. Its largest new stake was DYAX CORPORATION: 687,600 shares worth $25.9M.
By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 98% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Medtronic, an estimated $5.89M trimmed.
- Sio Capital Management's largest Q4 2015 buy was DYAX CORPORATION: 687,600 shares worth $25.9M.
- Sio Capital Management added most to Sanofi in Q4 2015, an estimated $10.6M increase.
- Sio Capital Management's biggest Q4 2015 reduction was Medtronic, cutting an estimated $5.89M.
- Sio Capital Management fully exited Johnson & Johnson in Q4 2015, selling an estimated $7.98M.
- Sio Capital Management's ten largest holdings make up 58% of its $226M portfolio in Q4 2015.
- Sio Capital Management opened 20 new positions and closed 12 in Q4 2015.
- Sio Capital Management's portfolio value rose 55% quarter-over-quarter to $226M.
Based on Sio Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.